,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,5.71830674825435e-07,0.000470044814706507
2,WP_SPINAL_CORD_INJURY,65,Down,1.42115336644861e-06,0.00058409403361038
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,6.62014547987634e-06,0.00181391986148612
4,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,5.58410436911669e-05,0.0114753344785348
5,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Down,9.59844709107284e-05,0.0157798470177238
6,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.000121327647769465,0.0166218877444166
7,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.000192672312943441,0.022625234462787
8,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.00022517589713736,0.0231368234308637
9,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,35,Down,0.000603899831076109,0.055156184571618
10,WP_IL26_SIGNALING,31,Down,0.00101079244100983,0.0675084912887814
11,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,0.00105575717259903,0.0675084912887814
12,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.001102563304997,0.0675084912887814
13,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.00118183989243266,0.0675084912887814
14,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Down,0.0012316929801628,0.0675084912887814
15,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00123190677534273,0.0675084912887814
16,WP_MEVALONATE_PATHWAY,7,Down,0.00166232044926947,0.0825715709777796
17,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.00170768455793461,0.0825715709777796
18,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.00210960394443979,0.0963385801294172
19,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0023125594449546,0.0972096568458353
20,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.00236519846340232,0.0972096568458353
21,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00291061280804208,0.113929701343361
22,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.00388406546032024,0.145081105232497
23,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.00405944698339105,0.145081105232497
24,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00461056336615059,0.149553588593684
25,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.00467262767479841,0.149553588593684
26,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.00475153695241257,0.149553588593684
27,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.00491234415088742,0.149553588593684
28,WP_COMPLEMENT_ACTIVATION,12,Up,0.00580026618532141,0.159077288529978
29,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.00583771856625777,0.159077288529978
30,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00590752535657075,0.159077288529978
31,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.00599926513920841,0.159077288529978
32,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.00662073602937106,0.170070156754469
33,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.00734719690633265,0.183011995666831
34,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,35,Down,0.00788277992854857,0.185731304818136
35,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.00797606718950981,0.185731304818136
36,WP_NEUROINFLAMMATION,10,Down,0.00821655125169284,0.185731304818136
37,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.00836016822174093,0.185731304818136
38,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.00907448208329055,0.191634120830826
39,WP_IL1_SIGNALING,53,Down,0.00909212982044063,0.191634120830826
40,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0096754007499872,0.192044112438911
41,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.00970955403321179,0.192044112438911
42,WP_GASTRIN_SIGNALING,92,Down,0.0100044035517436,0.192044112438911
43,WP_HYPERTROPHY_MODEL,13,Down,0.0102181122033886,0.192044112438911
44,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.0102993128733084,0.192044112438911
45,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.0105133638196484,0.192044112438911
46,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.0110961074396714,0.198282615552389
47,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0113542894624883,0.198579275280115
48,WP_KETOGENESIS_AND_KETOLYSIS,7,Up,0.0163202966779998,0.279485080610746
49,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.0172717708243682,0.287322868112698
50,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0176154771015728,0.287322868112698
51,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.0178266013062623,0.287322868112698
52,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.0192086292663004,0.30364410109421
53,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.0211877490819984,0.326863625371701
54,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.02147279290763,0.326863625371701
55,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0234011042345118,0.349740139650341
56,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.0244017419315242,0.352236396870174
57,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.0244251516077858,0.352236396870174
58,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0251205128690132,0.356018303074636
59,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.0272647435259387,0.375883977367539
60,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.0274367866691634,0.375883977367539
61,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0282007309053789,0.379463395736574
62,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.0287249595831784,0.379463395736574
63,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.0290829609871097,0.379463395736574
64,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.0296794037711544,0.381194842185764
65,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.0309290215868118,0.385203308679875
66,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.0315865428624429,0.385203308679875
67,WP_NETRINUNC5B_SIGNALING,34,Down,0.0324814836172656,0.385203308679875
68,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0326779339133592,0.385203308679875
69,WP_SEROTONIN_AND_ANXIETY,6,Down,0.0333315367434671,0.385203308679875
70,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0344683188353133,0.385203308679875
71,WP_FOXP3_IN_COVID19,9,Down,0.0349241093579864,0.385203308679875
72,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.0349795693447592,0.385203308679875
73,WP_REGULATION_OF_ACTIN_CYTOSKELETON,91,Down,0.0351280996045349,0.385203308679875
74,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.0352184593551516,0.385203308679875
75,WP_IRINOTECAN_PATHWAY,5,Up,0.0356901302380233,0.385203308679875
76,WP_PEPTIDE_GPCRS,11,Down,0.0365649267437619,0.385203308679875
77,WP_ASPIRIN_AND_MIRNAS,8,Down,0.036580389048712,0.385203308679875
78,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0366641005695708,0.385203308679875
79,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.0371455570288264,0.385203308679875
80,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.0374893731075304,0.385203308679875
81,WP_HIPPOYAP_SIGNALING,16,Down,0.0380263919167859,0.385897458711086
82,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.0397937950658624,0.393173956148756
83,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0398468532921326,0.393173956148756
84,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.0411605480926141,0.393173956148756
85,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Down,0.0417049120137833,0.393173956148756
86,WP_CHEMOKINE_SIGNALING,105,Down,0.0424438758683435,0.393173956148756
87,WP_BREAST_CANCER_PATHWAY,88,Down,0.042490657682807,0.393173956148756
88,WP_BURN_WOUND_HEALING,60,Down,0.0426731125927523,0.393173956148756
89,WP_CHOLESTEROL_METABOLISM,50,Down,0.0432742927192786,0.393173956148756
90,WP_ONCOSTATIN_M_SIGNALING,54,Down,0.0437164074001258,0.393173956148756
91,WP_PLEURAL_MESOTHELIOMA,251,Down,0.0439931036474347,0.393173956148756
92,WP_TNFALPHA_SIGNALING,83,Down,0.0440696170433437,0.393173956148756
93,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.0456548117190565,0.393173956148756
94,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.0458232919469757,0.393173956148756
95,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.0459018688240872,0.393173956148756
96,WP_NRXN1_DELETION_SYNDROME,2,Up,0.0460060717192988,0.393173956148756
97,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0463964400808143,0.393173956148756
98,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.0484199905500281,0.406135022776766
99,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.0521602356768533,0.432110056675692
100,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,75,Down,0.0525681334155343,0.432110056675692
101,WP_RANKLRANK_SIGNALING,48,Down,0.0538181996566501,0.438005545720459
102,WP_AGERAGE_PATHWAY,54,Down,0.0548660474962842,0.438641015409351
103,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0554203674442759,0.438641015409351
104,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.0568594432074578,0.438641015409351
105,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.0585204175745686,0.438641015409351
106,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0589468479029641,0.438641015409351
107,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.0590796585059819,0.438641015409351
108,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.0593624317371335,0.438641015409351
109,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.0600142376344925,0.438641015409351
110,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.0605407195551313,0.438641015409351
111,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.060689016064238,0.438641015409351
112,WP_IRON_METABOLISM_DISORDERS,12,Down,0.0608031672199489,0.438641015409351
113,WP_CCL18_SIGNALING,20,Down,0.0613489353528732,0.438641015409351
114,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.062310807878493,0.438641015409351
115,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.0624881929998719,0.438641015409351
116,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.0627623147850062,0.438641015409351
117,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.0629325456295724,0.438641015409351
118,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.0629679316524372,0.438641015409351
119,WP_GPR40_PATHWAY,10,Up,0.0669222228548661,0.458619232560377
120,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0669517127825368,0.458619232560377
121,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.0675627540910266,0.458980031924164
122,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.068517986084517,0.461653971815352
123,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.0692142981749929,0.462554090242636
124,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0704555895478203,0.467052375873454
125,WP_FOCAL_ADHESION,114,Down,0.0715654447815143,0.467562443801353
126,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.0724391244712538,0.467562443801353
127,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.0737419727411028,0.467562443801353
128,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.0738404630321122,0.467562443801353
129,WP_NAD_METABOLISM,11,Down,0.0745792272867021,0.467562443801353
130,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.0746850775152372,0.467562443801353
131,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.0750159976161334,0.467562443801353
132,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0756954837302941,0.467562443801353
133,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.0761219623091485,0.467562443801353
134,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0762206416902449,0.467562443801353
135,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0769204214887408,0.468359899731444
136,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.0779118863606238,0.468546705769367
137,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.0789169597047704,0.468546705769367
138,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0793638740558954,0.468546705769367
139,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.0793639244816664,0.468546705769367
140,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.0798011421018387,0.468546705769367
141,WP_ECTODERM_DIFFERENTIATION,75,Down,0.0837405596253096,0.46929029803959
142,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,5,Down,0.0843433240997211,0.46929029803959
143,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.0848416394479445,0.46929029803959
144,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0849645054428895,0.46929029803959
145,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.0855444952454184,0.46929029803959
146,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.0856362718739679,0.46929029803959
147,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.0868283626291285,0.46929029803959
148,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.087038400571722,0.46929029803959
149,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.0871140536139547,0.46929029803959
150,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.0874883296776035,0.46929029803959
151,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.0875802049077352,0.46929029803959
152,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.088268642882711,0.46929029803959
153,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.0886411131972879,0.46929029803959
154,WP_PROLACTIN_SIGNALING,69,Down,0.0888474694954541,0.46929029803959
155,WP_EGFEGFR_SIGNALING,138,Down,0.0889762120437727,0.46929029803959
156,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.0890623923286814,0.46929029803959
157,WP_AMINO_ACID_METABOLISM,57,Up,0.090420175009313,0.47341008826532
158,WP_PPAR_SIGNALING,38,Up,0.0917588125999246,0.476461999460588
159,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.0929667732650446,0.476461999460588
160,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.0931872095243213,0.476461999460588
161,WP_DRAVET_SYNDROME,12,Down,0.093321632497755,0.476461999460588
162,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.0950588049925521,0.481285128646573
163,WP_DOPAMINE_METABOLISM,7,Up,0.0956833220108162,0.481285128646573
164,WP_G13_SIGNALING,30,Down,0.0962908003023957,0.481285128646573
165,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.0966083287429251,0.481285128646573
166,WP_NOTCH_SIGNALING_WP61,49,Down,0.097555559362428,0.482815449053699
167,WP_13Q1212_COPY_NUMBER_VARIATION,19,Down,0.0984266133466438,0.482815449053699
168,WP_GASTRIC_CANCER_NETWORK_2,27,Down,0.0986776100255736,0.482815449053699
169,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,10,Down,0.100111979789726,0.486935191639969
170,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Down,0.101052643787076,0.488619254076334
171,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.104024814479911,0.499015444467135
172,WP_CELL_DIFFERENTIATION_INDEX,6,Down,0.104740028009947,0.499015444467135
173,WP_ANGIOGENESIS,13,Down,0.10559004790527,0.499015444467135
174,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,30,Down,0.106036829807074,0.499015444467135
175,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.10733909625853,0.499015444467135
176,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.107462043366422,0.499015444467135
177,WP_MAPK_CASCADE,30,Down,0.10801731849803,0.499015444467135
178,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.108059305492883,0.499015444467135
179,WP_NEPHROTIC_SYNDROME,29,Down,0.109027732853414,0.499502512508679
180,WP_MAPK_SIGNALING,159,Down,0.109380112228178,0.499502512508679
181,WP_MELANOMA,56,Down,0.111897089403681,0.502762546483524
182,WP_GPCRS_OTHER,11,Down,0.113164136497524,0.502762546483524
183,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.113457692920821,0.502762546483524
184,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Down,0.113468889175357,0.502762546483524
185,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.114240158211222,0.502762546483524
186,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Down,0.114331804335899,0.502762546483524
187,WP_PPARALPHA_PATHWAY,15,Up,0.114726470406897,0.502762546483524
188,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.115383800922017,0.502762546483524
189,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.115670176858012,0.502762546483524
190,WP_WNT_SIGNALING_WP363,37,Down,0.11674578641945,0.502762546483524
191,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.116821954231573,0.502762546483524
192,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.118695292796172,0.50816422228361
193,WP_HEART_DEVELOPMENT,16,Down,0.11953495532735,0.509107426316484
194,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.120559786819035,0.510825488480652
195,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.121741720538963,0.513188175810396
196,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.123145801670041,0.516458413126395
197,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.127950182545213,0.53388350280287
198,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.130197603498664,0.540517323615668
199,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Down,0.131051088072207,0.540571768011483
200,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.131525977618366,0.540571768011483
201,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.1324843923568,0.5418018433696
202,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.133371870008623,0.542731074985585
203,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.134710268694059,0.543577377941053
204,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.135841584108359,0.543577377941053
205,WP_PDGF_PATHWAY,36,Down,0.136237828929406,0.543577377941053
206,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.137339267884831,0.543577377941053
207,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.13791213522132,0.543577377941053
208,WP_MONOAMINE_GPCRS,3,Down,0.138865540657539,0.543577377941053
209,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.139055044753053,0.543577377941053
210,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.139404367420729,0.543577377941053
211,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.139531419398494,0.543577377941053
212,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.142203679630539,0.548975203337064
213,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.142608147452984,0.548975203337064
214,WP_METHYLATION_PATHWAYS,5,Up,0.14336171027732,0.548975203337064
215,WP_RETINOBLASTOMA_GENE_IN_CANCER,85,Down,0.144383602199219,0.548975203337064
216,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.144848945457413,0.548975203337064
217,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.14705392977077,0.548975203337064
218,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.14821063803883,0.548975203337064
219,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.1488262420053,0.548975203337064
220,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.1488262420053,0.548975203337064
221,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.148848157010703,0.548975203337064
222,WP_AEROBIC_GLYCOLYSIS,10,Up,0.148931229129155,0.548975203337064
223,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.148931229129155,0.548975203337064
224,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.151561718066292,0.556177376118269
225,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.154424402402614,0.56416381677755
226,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.155608571385532,0.565974538402246
227,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.157014115702031,0.568570938797664
228,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Up,0.158347905499894,0.568799749236125
229,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.158660534281412,0.568799749236125
230,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Up,0.159153214506458,0.568799749236125
231,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.161563876021398,0.574915610777443
232,WP_COMPLEMENT_SYSTEM,51,Up,0.162614176381477,0.57615884907575
233,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.163565038737965,0.577040608766554
234,WP_WNT_SIGNALING_WP428,56,Down,0.165518820516608,0.578441582785631
235,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,86,Down,0.16622847933176,0.578441582785631
236,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.166411130363909,0.578441582785631
237,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.168164562260435,0.578441582785631
238,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,30,Down,0.168274832654796,0.578441582785631
239,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.168382783870954,0.578441582785631
240,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.169449656057285,0.578441582785631
241,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Down,0.169837717482602,0.578441582785631
242,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Down,0.170295453812801,0.578441582785631
243,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.173559462508258,0.584890400321576
244,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.174046419488918,0.584890400321576
245,WP_ZINC_HOMEOSTASIS,23,Up,0.175082042245893,0.584890400321576
246,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.176149091464714,0.584890400321576
247,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.176845587622968,0.584890400321576
248,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.177174829294492,0.584890400321576
249,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.177174829294492,0.584890400321576
250,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.18338886407447,0.596866696555503
251,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.18387005651241,0.596866696555503
252,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.183879124817588,0.596866696555503
253,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Down,0.184033531842695,0.596866696555503
254,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Down,0.184433261466056,0.596866696555503
255,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.187237292418084,0.599442822488813
256,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.187270869933941,0.599442822488813
257,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.187417038174726,0.599442822488813
258,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.188610311671661,0.600921225558548
259,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.189501267091895,0.601428731851498
260,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.19073972724747,0.603030983836233
261,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.192958566431395,0.607708588531061
262,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.195820087357903,0.614366838962582
263,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.198585914043757,0.61771025667897
264,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.198803341867091,0.61771025667897
265,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.199140167907454,0.61771025667897
266,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,9,Down,0.206440996185876,0.636026582058627
267,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.206592575924153,0.636026582058627
268,WP_ALLOGRAFT_REJECTION,49,Down,0.209187544142586,0.641612542108978
269,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.212245493372862,0.64857173067841
270,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.213470422897128,0.649898843042366
271,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.21833178699652,0.662246232144426
272,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.219524521343459,0.663416016707072
273,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.220366398959579,0.663520805658512
274,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Up,0.221743597114265,0.665230791342794
275,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.223401113709768,0.667766238070651
276,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.22426849880392,0.66793009426385
277,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.226066404234458,0.670191534281394
278,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,53,Up,0.226927553453366,0.670191534281394
279,WP_ENDOMETRIAL_CANCER,49,Down,0.229597214178558,0.670191534281394
280,WP_MONOAMINE_TRANSPORT,12,Down,0.230506993263584,0.670191534281394
281,WP_HEPATITIS_B_INFECTION,116,Down,0.231026896774958,0.670191534281394
282,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.232930287296849,0.670191534281394
283,WP_TOLLLIKE_RECEPTOR_SIGNALING,78,Down,0.233120531364491,0.670191534281394
284,WP_VEGFAVEGFR2_SIGNALING,342,Down,0.233994596294402,0.670191534281394
285,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.234141225449717,0.670191534281394
286,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.2351601972418,0.670191534281394
287,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.235535974284503,0.670191534281394
288,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.235708646270301,0.670191534281394
289,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.235891599460661,0.670191534281394
290,WP_VITAMIN_B12_METABOLISM,23,Down,0.236442268785407,0.670191534281394
291,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Down,0.237623937484092,0.671226380109704
292,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.239527481136603,0.673183120438472
293,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.239954567260915,0.673183120438472
294,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.243679506464878,0.680450863709798
295,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.244200735759599,0.680450863709798
296,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.248365460146838,0.689717595407773
297,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.250073491965614,0.692122593925033
298,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,28,Down,0.251292790546885,0.693163334998454
299,WP_SPINA_BIFIDA,10,Up,0.254013082706645,0.698180605881435
300,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.254810440102713,0.698180605881435
301,WP_P38_MAPK_SIGNALING,31,Down,0.256148691650244,0.699515696134552
302,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.257061584908038,0.699684181438433
303,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Down,0.258007250655461,0.69994046217422
304,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.263114759824422,0.711448462419983
305,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.267206832947659,0.719586807990248
306,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,40,Down,0.267875381076662,0.719586807990248
307,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.270370860337113,0.723924583703931
308,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.273255268737329,0.726377013721661
309,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.27437821371942,0.726377013721661
310,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.275035944203106,0.726377013721661
311,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,24,Up,0.277093573908929,0.726377013721661
312,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Down,0.277263310968399,0.726377013721661
313,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.277453660064472,0.726377013721661
314,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.277472484560342,0.726377013721661
315,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.279519626795727,0.729413121352659
316,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.281782732741241,0.730319485287591
317,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Up,0.282687874917648,0.730319485287591
318,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Up,0.282687874917648,0.730319485287591
319,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.283420822149321,0.730319485287591
320,WP_CIRCADIAN_RHYTHM_GENES,118,Down,0.284657822328317,0.731214781105865
321,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.285784381941429,0.731821688335996
322,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.290856438649778,0.740909053912678
323,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.291318963937929,0.740909053912678
324,WP_CANCER_PATHWAYS,300,Down,0.292037145337844,0.740909053912678
325,WP_BLADDER_CANCER,29,Down,0.292957972322015,0.740958317688296
326,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.295664914975631,0.743233724274674
327,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.295665970605619,0.743233724274674
328,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.298079359796682,0.747015956563637
329,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.302480086899214,0.755740521067338
330,WP_TAMOXIFEN_METABOLISM,2,Up,0.303980312823813,0.757187324670225
331,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.305807733036413,0.758619750475134
332,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.30640116442548,0.758619750475134
333,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.30899462372871,0.7627434856006
334,WP_MACROPHAGE_MARKERS,8,Up,0.3105908380739,0.764388230229777
335,WP_SPHINGOLIPID_PATHWAY,20,Down,0.313137302272167,0.767093499922886
336,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.313601521144871,0.767093499922886
337,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.315353911900564,0.767093499922886
338,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Up,0.315422874664155,0.767093499922886
339,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.317662844525886,0.768668568713532
340,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.318455255683758,0.768668568713532
341,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.31887589042739,0.768668568713532
342,WP_GLUTATHIONE_METABOLISM,10,Down,0.320956176976111,0.771420986767145
343,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.32261780646445,0.773154043480403
344,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.324719962088077,0.774505592452673
345,WP_PRIMARY_OVARIAN_INSUFFICIENCY,96,Down,0.32597910025239,0.774505592452673
346,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,15,Down,0.326008436725821,0.774505592452673
347,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.327937057058682,0.77460994512137
348,WP_HEME_BIOSYNTHESIS,8,Down,0.327937057058682,0.77460994512137
349,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.328883052794344,0.774618536954013
350,WP_INSULIN_SIGNALING,130,Down,0.330958445247911,0.777279548553665
351,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,89,Down,0.333213609316641,0.779461268176559
352,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.335027591149312,0.779461268176559
353,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.336277009925454,0.779461268176559
354,WP_ENDOTHELIN_PATHWAYS,12,Down,0.336587271217175,0.779461268176559
355,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Up,0.338017034741675,0.779461268176559
356,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Down,0.338120487501826,0.779461268176559
357,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.338857276512885,0.779461268176559
358,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Down,0.340415468702133,0.779461268176559
359,WP_ARYLAMINE_METABOLISM,1,Up,0.341351459833621,0.779461268176559
360,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,4,Up,0.341698640884245,0.779461268176559
361,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.342318148189462,0.779461268176559
362,WP_HOMOLOGOUS_RECOMBINATION,13,Down,0.351068971919436,0.792575406404268
363,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.35258312934421,0.792575406404268
364,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.352845084929664,0.792575406404268
365,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.352865192042096,0.792575406404268
366,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,124,Down,0.353068819809456,0.792575406404268
367,WP_15Q11Q13_COPY_NUMBER_VARIATION,30,Up,0.354145878862045,0.792575406404268
368,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.355828740017361,0.792575406404268
369,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,25,Down,0.356560558926341,0.792575406404268
370,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.356755353247663,0.792575406404268
371,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.359573503713762,0.796683072918363
372,WP_MIRNA_BIOGENESIS,6,Up,0.362204333255159,0.799638701221881
373,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,8,Down,0.362853084617715,0.799638701221881
374,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.365777157200677,0.802083053068621
375,WP_DISORDERS_IN_KETOLYSIS,5,Down,0.366427281462662,0.802083053068621
376,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.366889571719953,0.802083053068621
377,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.371160649822307,0.809268048153677
378,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.372949718551019,0.811017641928406
379,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.374499145546016,0.812238252345185
380,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.377774814537334,0.813049477030511
381,WP_APOPTOSIS,71,Down,0.378063675300657,0.813049477030511
382,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.378799865118205,0.813049477030511
383,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.379275888049819,0.813049477030511
384,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.38023016853344,0.813049477030511
385,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.381208303994179,0.813049477030511
386,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.381990949815026,0.813049477030511
387,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Down,0.382786067653051,0.813049477030511
388,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.387228346996108,0.820365209357734
389,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.388907466202967,0.821804465858197
390,WP_IDO_METABOLIC_PATHWAY,6,Down,0.393238157697305,0.826760711681046
391,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.393264523439524,0.826760711681046
392,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.394437927642587,0.827112185005629
393,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.397314599704315,0.828317696837218
394,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.39871960398306,0.828317696837218
395,WP_VALPROIC_ACID_PATHWAY,8,Up,0.399131088322307,0.828317696837218
396,WP_15Q25_COPY_NUMBER_VARIATION,27,Down,0.400169148657692,0.828317696837218
397,WP_CELL_CYCLE,107,Down,0.400521830499104,0.828317696837218
398,WP_PURINERGIC_SIGNALING,14,Down,0.401058933505125,0.828317696837218
399,WP_CILIARY_LANDSCAPE,185,Down,0.403361977803657,0.830986330212044
400,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.40492572347718,0.832122361745604
401,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.408471242310355,0.835733182178656
402,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.409762509971837,0.835733182178656
403,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.414302924513787,0.835733182178656
404,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.414409247963985,0.835733182178656
405,WP_CREATINE_PATHWAY,2,Up,0.414730375687637,0.835733182178656
406,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.416217210237214,0.835733182178656
407,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.416625432587923,0.835733182178656
408,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,53,Down,0.416984430795284,0.835733182178656
409,WP_STEROID_BIOSYNTHESIS,2,Up,0.417989529084064,0.835733182178656
410,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.418505404322111,0.835733182178656
411,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.418796822816912,0.835733182178656
412,WP_ERBB_SIGNALING,68,Down,0.4202475153255,0.835733182178656
413,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.420338093453412,0.835733182178656
414,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.421670158051447,0.835733182178656
415,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.422549541838338,0.835733182178656
416,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.423901531413016,0.835733182178656
417,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,2,Down,0.423966833295012,0.835733182178656
418,WP_AXON_GUIDANCE,35,Down,0.428450821539201,0.842551615562735
419,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,12,Up,0.429552176936686,0.842701406782711
420,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.433985932795061,0.845919266331184
421,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.434051945428861,0.845919266331184
422,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.436552238153196,0.845919266331184
423,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.436897475271947,0.845919266331184
424,WP_NEPHROGENESIS,4,Up,0.437322256292367,0.845919266331184
425,WP_THERMOGENESIS,73,Down,0.43736701726369,0.845919266331184
426,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.438641287404766,0.846392343302155
427,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.442522032697907,0.851880821727587
428,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.444461431008761,0.853615178245798
429,WP_BENZENE_METABOLISM,3,Up,0.447540731144008,0.855167743379246
430,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.448146781268984,0.855167743379246
431,WP_NEURAL_CREST_DIFFERENTIATION,38,Down,0.448390872745079,0.855167743379246
432,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Down,0.452169233900418,0.858400493327641
433,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.452174469112979,0.858400493327641
434,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.457010877895487,0.861049117978001
435,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,23,Up,0.457086918663965,0.861049117978001
436,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Down,0.458049570342449,0.861049117978001
437,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.459366156673051,0.861049117978001
438,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.460516812663698,0.861049117978001
439,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.461752068557494,0.861049117978001
440,WP_IL6_SIGNALING,39,Down,0.462138473830796,0.861049117978001
441,WP_G1_TO_S_CELL_CYCLE_CONTROL,57,Down,0.462519056166522,0.861049117978001
442,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.463801920127813,0.861049117978001
443,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.46404471929958,0.861049117978001
444,WP_MEASLES_VIRUS_INFECTION,101,Up,0.465720173222514,0.862211672047086
445,WP_ALZHEIMERS_DISEASE,184,Down,0.470316145834942,0.865766225834513
446,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.470316145834942,0.865766225834513
447,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.471711893836403,0.865766225834513
448,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.472679600821318,0.865766225834513
449,WP_SLEEP_REGULATION,10,Up,0.473150959489142,0.865766225834513
450,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.474269626683957,0.865766225834513
451,WP_TYPE_II_INTERFERON_SIGNALING,29,Down,0.475012856266868,0.865766225834513
452,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.476086626478947,0.865803555233837
453,WP_ENERGY_METABOLISM,40,Down,0.478430458115114,0.868145334592988
454,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.482199591637923,0.873057410410513
455,WP_RAS_SIGNALING,115,Up,0.486473116415148,0.878859124600553
456,WP_ONECARBON_METABOLISM,23,Up,0.491760140294306,0.886462358162105
457,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.493526095305893,0.887699016064428
458,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.49586168646055,0.889952633778542
459,WP_ETHER_LIPID_BIOSYNTHESIS,15,Up,0.49722318365882,0.890451975964162
460,WP_CYTOSINE_METHYLATION,7,Down,0.499824812200513,0.891318921203154
461,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.501274504738433,0.891318921203154
462,WP_NPHP1_DELETION_SYNDROME,10,Down,0.501864912981272,0.891318921203154
463,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.502044599169173,0.891318921203154
464,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.508621557723399,0.901049397518608
465,WP_DNA_DAMAGE_RESPONSE,63,Down,0.510679036973447,0.901632659199347
466,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.511332881951193,0.901632659199347
467,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.512565944099491,0.901632659199347
468,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.513338302317876,0.901632659199347
469,WP_PRION_DISEASE_PATHWAY,28,Down,0.519908170634052,0.907320315277005
470,WP_IL3_SIGNALING,46,Down,0.519969646396045,0.907320315277005
471,WP_FOLATE_METABOLISM,36,Down,0.520226033881659,0.907320315277005
472,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.520991713881687,0.907320315277005
473,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Down,0.522375356494495,0.907806644901638
474,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.526735751701288,0.911516241229009
475,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Down,0.527396957079124,0.911516241229009
476,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.528745557359667,0.911516241229009
477,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.529077628605132,0.911516241229009
478,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,14,Down,0.530054456578426,0.911516241229009
479,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,75,Down,0.535675072374441,0.919258683698937
480,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.539182625229827,0.921582383979439
481,WP_TCELL_RECEPTOR_SIGNALING,72,Down,0.54017615362436,0.921582383979439
482,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.54039259011933,0.921582383979439
483,WP_TGFB_SMAD_SIGNALING,7,Down,0.542133687537045,0.921863666933975
484,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.543717589346742,0.921863666933975
485,WP_MALE_INFERTILITY,70,Up,0.544026614575135,0.921863666933975
486,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.545043481909868,0.921863666933975
487,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.547517214700774,0.924146099556543
488,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Down,0.549713322828724,0.924551702141534
489,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.551581015844081,0.924551702141534
490,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.551635495088867,0.924551702141534
491,WP_VITAMIN_B12_DISORDERS,9,Down,0.552256552009116,0.924551702141534
492,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.553819122510474,0.925217006199177
493,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.555789074921668,0.925217006199177
494,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.556237222155678,0.925217006199177
495,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.559907321887414,0.925217006199177
496,WP_ATM_SIGNALING,37,Down,0.560160365742384,0.925217006199177
497,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.560317282438477,0.925217006199177
498,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Down,0.560532930763005,0.925217006199177
499,WP_IL18_SIGNALING,191,Down,0.564099863279826,0.926317182142619
500,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.564196832159175,0.926317182142619
501,WP_PYRIMIDINE_METABOLISM,74,Down,0.566254488804972,0.926317182142619
502,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.567661939003755,0.926317182142619
503,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.570135866609236,0.926317182142619
504,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.57185161916836,0.926317182142619
505,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.572366046574055,0.926317182142619
506,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Down,0.574522622163642,0.926317182142619
507,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Down,0.57695655066286,0.926317182142619
508,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.58037868975316,0.926317182142619
509,WP_ESTROGEN_SIGNALING,21,Down,0.581166482652178,0.926317182142619
510,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Up,0.581344600000647,0.926317182142619
511,WP_GASTRIC_CANCER_NETWORK_1,21,Down,0.582555964576242,0.926317182142619
512,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.582903377120166,0.926317182142619
513,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.583664493847082,0.926317182142619
514,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.58407980589549,0.926317182142619
515,WP_NRF2_PATHWAY,66,Up,0.584085999315124,0.926317182142619
516,WP_KREBS_CYCLE_DISORDERS,11,Up,0.585829697318672,0.926317182142619
517,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Up,0.586669754807069,0.926317182142619
518,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.586796474303973,0.926317182142619
519,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.586942254509701,0.926317182142619
520,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.586951551768219,0.926317182142619
521,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Down,0.588078300432819,0.926317182142619
522,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.589741787541035,0.926317182142619
523,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.5904292322129,0.926317182142619
524,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.590499030952229,0.926317182142619
525,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.592648917867137,0.926555617152863
526,WP_OVARIAN_INFERTILITY,23,Down,0.594599126621385,0.926555617152863
527,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.598847983546777,0.926555617152863
528,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.601276307631046,0.926555617152863
529,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Up,0.603235062625708,0.926555617152863
530,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.604940078480578,0.926555617152863
531,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.60532864206307,0.926555617152863
532,WP_DNA_REPLICATION,41,Down,0.608057691170762,0.926555617152863
533,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.608251860983721,0.926555617152863
534,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.608941298269593,0.926555617152863
535,WP_HISTONE_MODIFICATIONS,37,Up,0.611739059391311,0.926555617152863
536,WP_PHOSPHOINOSITIDES_METABOLISM,39,Up,0.612355349306081,0.926555617152863
537,WP_ENDODERM_DIFFERENTIATION,80,Up,0.612588431692837,0.926555617152863
538,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.613169054715682,0.926555617152863
539,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.61511459332409,0.926555617152863
540,WP_IL19_SIGNALING,20,Down,0.615313218482343,0.926555617152863
541,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.616671302477316,0.926555617152863
542,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.618794625000037,0.926555617152863
543,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.619397353360952,0.926555617152863
544,WP_PREIMPLANTATION_EMBRYO,21,Down,0.619807678675593,0.926555617152863
545,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.619972159195872,0.926555617152863
546,WP_ADIPOGENESIS,83,Up,0.621147741070347,0.926555617152863
547,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,84,Down,0.621383238688064,0.926555617152863
548,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.626076195942094,0.926555617152863
549,WP_OSTEOBLAST_SIGNALING,2,Up,0.626739788999223,0.926555617152863
550,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.627253540134784,0.926555617152863
551,WP_G_PROTEIN_SIGNALING,61,Down,0.627609519243648,0.926555617152863
552,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.630066345601618,0.926555617152863
553,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.631249853718095,0.926555617152863
554,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.63184438266225,0.926555617152863
555,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.633449664783581,0.926555617152863
556,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.634344246347929,0.926555617152863
557,WP_MATRIX_METALLOPROTEINASES,8,Up,0.634756829865089,0.926555617152863
558,WP_GLUCURONIDATION,7,Down,0.634792987583651,0.926555617152863
559,WP_PDGFRBETA_PATHWAY,28,Down,0.63552680515941,0.926555617152863
560,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.635815062389816,0.926555617152863
561,WP_VITAMIN_D_METABOLISM,6,Up,0.636280174370234,0.926555617152863
562,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.639109568948548,0.926555617152863
563,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.639458645806945,0.926555617152863
564,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.639561667641621,0.926555617152863
565,WP_NUCLEOTIDE_GPCRS,5,Up,0.639740783919238,0.926555617152863
566,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.642048416927245,0.926555617152863
567,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.642064485204003,0.926555617152863
568,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.642516501018106,0.926555617152863
569,WP_ATR_SIGNALING,10,Down,0.642557933387693,0.926555617152863
570,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.643198039054536,0.926555617152863
571,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.644006968665098,0.926555617152863
572,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.644756463517564,0.926555617152863
573,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.648016188941753,0.929614846963561
574,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.651395338531204,0.931583144767156
575,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.653709677397735,0.931583144767156
576,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.654626400584486,0.931583144767156
577,WP_LEPTIN_SIGNALING,70,Down,0.656812303253814,0.931583144767156
578,WP_NUCLEAR_RECEPTORS,20,Up,0.657248736579175,0.931583144767156
579,WP_IL7_SIGNALING,22,Down,0.660025030037564,0.931583144767156
580,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.660258895124466,0.931583144767156
581,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.661111149285072,0.931583144767156
582,WP_AUTOPHAGY,27,Down,0.662344782955635,0.931583144767156
583,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.662380059216671,0.931583144767156
584,WP_NRF2ARE_REGULATION,20,Up,0.664439199633483,0.931583144767156
585,WP_CELLULAR_PROTEOSTASIS,6,Down,0.665039996735201,0.931583144767156
586,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.666282107122165,0.931583144767156
587,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.666387942972126,0.931583144767156
588,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.666387942972126,0.931583144767156
589,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.668346696154113,0.932735117552939
590,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Up,0.670262969524794,0.933469439139606
591,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.6716641074668,0.933469439139606
592,WP_IL5_SIGNALING,37,Down,0.673837218112288,0.933469439139606
593,WP_LUNG_FIBROSIS,30,Down,0.674832766436095,0.933469439139606
594,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.675990844050579,0.933469439139606
595,WP_SILDENAFIL_TREATMENT,11,Up,0.677185081530001,0.933469439139606
596,WP_GLYOXYLATE_METABOLISM,5,Up,0.679825942914784,0.933469439139606
597,WP_ALSTROM_SYNDROME,26,Down,0.68056359915201,0.933469439139606
598,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.680703146278541,0.933469439139606
599,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.681137743541743,0.933469439139606
600,WP_HUNGER_AND_SATIETY,2,Down,0.683449590385213,0.933469439139606
601,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.683886812140449,0.933469439139606
602,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.68502762843721,0.933469439139606
603,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.685872033039097,0.933469439139606
604,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.685906984477277,0.933469439139606
605,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.69073776924141,0.93673093319955
606,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.693600670403062,0.93673093319955
607,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.694480373666171,0.93673093319955
608,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.695957492089102,0.93673093319955
609,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.698341978333728,0.93673093319955
610,WP_10Q22Q23_COPY_NUMBER_VARIATION,28,Up,0.698498656930366,0.93673093319955
611,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,64,Down,0.700006615103924,0.93673093319955
612,WP_IL4_SIGNALING,50,Down,0.700334645683321,0.93673093319955
613,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.700433829584333,0.93673093319955
614,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.700881124719157,0.93673093319955
615,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Up,0.701629592357268,0.93673093319955
616,WP_TRYPTOPHAN_METABOLISM,17,Down,0.705236477590854,0.93673093319955
617,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.707467040764101,0.93673093319955
618,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,45,Up,0.707479606204193,0.93673093319955
619,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.707880124645088,0.93673093319955
620,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.708016595929726,0.93673093319955
621,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.70808894119594,0.93673093319955
622,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,13,Up,0.709179963824244,0.93673093319955
623,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.71140814703691,0.93673093319955
624,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.711875765106425,0.93673093319955
625,WP_RETT_SYNDROME,31,Down,0.712234590328125,0.93673093319955
626,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.714285433426975,0.936917539624214
627,WP_MRNA_PROCESSING,124,Down,0.715816125882513,0.936917539624214
628,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.718302256176383,0.936917539624214
629,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Up,0.719288498743862,0.936917539624214
630,WP_CORI_CYCLE,11,Up,0.719836619838405,0.936917539624214
631,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.720061088484991,0.936917539624214
632,WP_OSTEOCLAST_SIGNALING,8,Down,0.720355091292583,0.936917539624214
633,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.725213808430972,0.940728271457831
634,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.726150547498861,0.940728271457831
635,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.727785373578489,0.940728271457831
636,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.727862750179052,0.940728271457831
637,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.731930057312737,0.94075296073296
638,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,7,Up,0.732401090558583,0.94075296073296
639,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.732445750329173,0.94075296073296
640,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.73245972611812,0.94075296073296
641,WP_SERINE_METABOLISM,8,Up,0.737090682356768,0.941850338403221
642,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.738821988099949,0.941850338403221
643,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.73902732085786,0.941850338403221
644,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.73922668155901,0.941850338403221
645,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Down,0.740164928938174,0.941850338403221
646,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.740467862353852,0.941850338403221
647,WP_FOXA2_PATHWAY,9,Up,0.741683431126963,0.941850338403221
648,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.742480558741225,0.941850338403221
649,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Up,0.74505415908708,0.942902141048795
650,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.747249303513266,0.942902141048795
651,WP_ENDOCHONDRAL_OSSIFICATION,27,Down,0.748817554308195,0.942902141048795
652,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Down,0.748817554308195,0.942902141048795
653,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,79,Down,0.749737579199197,0.942902141048795
654,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.753011137287318,0.942902141048795
655,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.754069404549004,0.942902141048795
656,WP_BARDETBIEDL_SYNDROME,64,Down,0.755309706835189,0.942902141048795
657,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.755673475889618,0.942902141048795
658,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.755762622043675,0.942902141048795
659,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Up,0.756376186941433,0.942902141048795
660,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.757317659498442,0.942902141048795
661,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.758221794687656,0.942902141048795
662,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.761289359700829,0.943449835071537
663,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.764361479707393,0.943449835071537
664,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.764501042458315,0.943449835071537
665,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Up,0.764774440364775,0.943449835071537
666,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.765496020668299,0.943449835071537
667,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.765643183232284,0.943449835071537
668,WP_BDNFTRKB_SIGNALING,27,Down,0.766960270485113,0.943449835071537
669,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Up,0.767844208835594,0.943449835071537
670,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,69,Down,0.772015858034215,0.944687367913652
671,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.773858570788458,0.944687367913652
672,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.775640447894757,0.944687367913652
673,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.775996981386438,0.944687367913652
674,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.776714146834355,0.944687367913652
675,WP_CHOLESTASIS,9,Down,0.776759230509755,0.944687367913652
676,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.776896180911957,0.944687367913652
677,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.779878764231189,0.94651426853192
678,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.781115093097593,0.94651426853192
679,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.782027444918796,0.94651426853192
680,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.783941833179175,0.94651426853192
681,WP_IL11_SIGNALING,41,Down,0.784155981593963,0.94651426853192
682,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.788052396124285,0.948765354462345
683,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Down,0.788329363865914,0.948765354462345
684,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.790187015609222,0.949534100132155
685,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.792592293029006,0.949534100132155
686,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.793184963215353,0.949534100132155
687,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.795638055312805,0.949534100132155
688,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.799499850342812,0.949534100132155
689,WP_FRAGILE_X_SYNDROME,83,Down,0.800597273245666,0.949534100132155
690,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.800943231806355,0.949534100132155
691,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,58,Down,0.801007568216518,0.949534100132155
692,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.801459605005101,0.949534100132155
693,WP_IL2_SIGNALING,36,Up,0.80163740221631,0.949534100132155
694,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.801674775537367,0.949534100132155
695,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.803576622259632,0.950232617446923
696,WP_BLOOD_CLOTTING_CASCADE,6,Down,0.805561165607757,0.950232617446923
697,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Up,0.808963084279072,0.950232617446923
698,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Down,0.808965121365341,0.950232617446923
699,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.809455469839266,0.950232617446923
700,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.811384008719639,0.950232617446923
701,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.811721342370537,0.950232617446923
702,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.812214623934715,0.950232617446923
703,WP_ID_SIGNALING,12,Down,0.812753923474044,0.950232617446923
704,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.814416745766496,0.950232617446923
705,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,171,Down,0.814980529562142,0.950232617446923
706,WP_PURINE_METABOLISM,10,Down,0.819510941341786,0.951473870936285
707,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.820164308384879,0.951473870936285
708,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.820756279895839,0.951473870936285
709,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.821694287157801,0.951473870936285
710,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.821832662244236,0.951473870936285
711,WP_EICOSANOID_SYNTHESIS,14,Up,0.824464220695834,0.953178044179994
712,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.826053131632412,0.953231285879674
713,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.826970904147507,0.953231285879674
714,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.82798921912176,0.953231285879674
715,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Up,0.83200929478813,0.956519776665515
716,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.834940569185091,0.958549089204113
717,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.836219481618327,0.958678401520593
718,WP_BASE_EXCISION_REPAIR,31,Up,0.83796193961703,0.959338042291363
719,WP_CILIOPATHIES,126,Down,0.843210974822204,0.964004758419822
720,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,34,Down,0.845248997794073,0.964436069611152
721,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.845934800717324,0.964436069611152
722,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.847165203439556,0.964501104192957
723,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.85027937171085,0.964865788867401
724,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.850395534979896,0.964865788867401
725,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.851006930570396,0.964865788867401
726,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.853174971197283,0.965991496314279
727,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.857391551272785,0.967532185127583
728,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.857537399147084,0.967532185127583
729,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.859170070800508,0.967532185127583
730,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Up,0.860021963283971,0.967532185127583
731,WP_COPPER_HOMEOSTASIS,40,Up,0.860420957820271,0.967532185127583
732,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.863944806676143,0.970167528808455
733,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.865707422124562,0.97082060161854
734,WP_TP53_NETWORK,16,Up,0.871411157032766,0.975557996395793
735,WP_DNA_MISMATCH_REPAIR,23,Down,0.872305507726165,0.975557996395793
736,WP_FLUOROPYRIMIDINE_ACTIVITY,27,Up,0.878360502032817,0.977183259172276
737,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.878819113535696,0.977183259172276
738,WP_PI3KAKT_SIGNALING,175,Down,0.879638565618325,0.977183259172276
739,WP_KININKALLIKREIN_PATHWAY,2,Down,0.880024641252336,0.977183259172276
740,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.880720972569237,0.977183259172276
741,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.881218265479453,0.977183259172276
742,WP_PROTEASOME_DEGRADATION,57,Down,0.882468254720573,0.977183259172276
743,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,21,Up,0.883269052998785,0.977183259172276
744,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.885742145830808,0.978016946991921
745,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.886402220813845,0.978016946991921
746,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Down,0.892317361736525,0.980821772934798
747,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.892724843347716,0.980821772934798
748,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.89458465213002,0.980821772934798
749,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Up,0.896374822489277,0.980821772934798
750,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.897868559243079,0.980821772934798
751,WP_IL17_SIGNALING,25,Down,0.898894323239246,0.980821772934798
752,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.900661111290851,0.980821772934798
753,WP_KLEEFSTRA_SYNDROME,24,Up,0.901030297908717,0.980821772934798
754,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.901325387408171,0.980821772934798
755,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,53,Down,0.901642400752357,0.980821772934798
756,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.903896491135603,0.980821772934798
757,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.906720376810299,0.980821772934798
758,WP_TRANSSULFURATION_PATHWAY,8,Up,0.908370622899852,0.980821772934798
759,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,28,Up,0.910783276502592,0.980821772934798
760,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.912868761613823,0.980821772934798
761,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.912951683354855,0.980821772934798
762,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.913411620070501,0.980821772934798
763,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Up,0.916178805288289,0.980821772934798
764,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.916234609285875,0.980821772934798
765,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.916369949231708,0.980821772934798
766,WP_FERROPTOSIS,50,Up,0.916452065146299,0.980821772934798
767,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Up,0.916801822491297,0.980821772934798
768,WP_KALLMANN_SYNDROME,11,Down,0.919004736193717,0.980821772934798
769,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Down,0.919187248474337,0.980821772934798
770,WP_NUCLEOTIDE_EXCISION_REPAIR,44,Down,0.919673450218014,0.980821772934798
771,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.919967867314756,0.980821772934798
772,WP_16P112_PROXIMAL_DELETION_SYNDROME,60,Down,0.923350410355482,0.983152898072806
773,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,119,Up,0.928257252441501,0.987098915274145
774,WP_RETINOL_METABOLISM,6,Up,0.930297527596185,0.987990397524631
775,WP_MITOCHONDRIAL_GENE_EXPRESSION,17,Down,0.931627721606058,0.988107855701254
776,WP_NOTCH_SIGNALING_WP268,35,Up,0.93281228226785,0.988107855701254
777,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Down,0.936456278118286,0.990082709163443
778,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.938505770676384,0.990082709163443
779,WP_JOUBERT_SYNDROME,70,Up,0.938852242955259,0.990082709163443
780,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.939494541541953,0.990082709163443
781,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.941296864221042,0.990289127515571
782,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.942099875568341,0.990289127515571
783,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.945804083020148,0.991940601036872
784,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.946084466195751,0.991940601036872
785,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.948231166051116,0.992924864323589
786,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.949469651966231,0.992956811598272
787,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.953179710751405,0.995570168027516
788,WP_TAR_SYNDROME,44,Down,0.95613987712615,0.99739464339809
789,WP_OSTEOPONTIN_SIGNALING,11,Down,0.958639735325881,0.997619596944208
790,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,24,Down,0.95996160857195,0.997619596944208
791,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Down,0.959996473458478,0.997619596944208
792,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.962515469528991,0.998301977566213
793,WP_IL9_SIGNALING,14,Down,0.963190199860652,0.998301977566213
794,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.964892835015249,0.998301977566213
795,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.96551103669725,0.998301977566213
796,WP_SMALL_LIGAND_GPCRS,7,Up,0.967967361830933,0.998419245437474
797,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.968963226151575,0.998419245437474
798,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.969268318563387,0.998419245437474
799,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.975188028488684,0.999146005672098
800,WP_CAMKK2_PATHWAY,29,Down,0.975461007874127,0.999146005672098
801,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.975653274522706,0.999146005672098
802,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.976016875207339,0.999146005672098
803,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.981012587336065,0.999146005672098
804,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Down,0.98118397930188,0.999146005672098
805,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.982993383490386,0.999146005672098
806,WP_TCELL_ACTIVATION_SARSCOV2,62,Up,0.983393209147086,0.999146005672098
807,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.983866368758215,0.999146005672098
808,WP_TRANSLATION_FACTORS,49,Up,0.984445582223745,0.999146005672098
809,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.985238221350649,0.999146005672098
810,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.985713804619892,0.999146005672098
811,WP_MTHFR_DEFICIENCY,18,Down,0.988048311060184,0.999146005672098
812,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.98875369870493,0.999146005672098
813,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.990818348527294,0.999146005672098
814,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Down,0.991464066293329,0.999146005672098
815,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.991789809914746,0.999146005672098
816,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.995094845679119,0.999146005672098
817,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.995436348150831,0.999146005672098
818,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,52,Down,0.995575824399577,0.999146005672098
819,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.995766600675462,0.999146005672098
820,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.996714993492847,0.999146005672098
821,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.998602305418165,0.999434640791066
822,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.999434640791066,0.999434640791066
